Literature DB >> 3154679

Role of calcium channel blockers in experimental exercise-induced ischemia.

E Thaulow1, B D Guth, J Ross.   

Abstract

Calcium channel blockers, which induce vasodilation by relaxing vascular smooth muscle cells, have proven effective in the treatment of angina pectoris. To study mechanisms of calcium blockade in ischemic heart disease, conscious chronically instrumented dogs with a single coronary artery ameroid constrictor were studied during steady-state treadmill runs which induced regional myocardial ischemia. During exercise-induced ischemia, regional systolic wall thickening and subendocardial blood flow were both significantly reduced in the ischemic zone. Calcium channel blockade with verapamil, diltiazem, or nifedipine enhanced regional systolic wall thickening. Regional subendocardial blood flow in the ischemic region, measured during diltiazem and nifedipine experiments, improved during exercise. Reduced coronary artery resistance in the native vessels and/or recruitment of collaterals appears to largely explain the increased total myocardial blood supply in the jeopardized area and the increased function. However, after diltiazem, reduced exercise heart rates as well as reduced left ventricular end-diastolic pressure also contributed to the improvement in the oxygen-supply imbalance in the ischemic myocardium. These data provide a basis for understanding the efficacy of calcium channel blocker treatment in patients with coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3154679     DOI: 10.1007/bf02125733

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  58 in total

Review 1.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

2.  Reduction of exercise-induced regional myocardial dysfunction by propranolol. Studies in a canine model of chronic coronary artery stenosis.

Authors:  T Kumada; K P Gallagher; K Shirato; D McKown; M Miller; W S Kemper; F White; J Ross
Journal:  Circ Res       Date:  1980-02       Impact factor: 17.367

3.  Dose response effectiveness of propranolol for the treatment of angina pectoris.

Authors:  E L Alderman; R O Davies; J J Crowley; M G Lopes; J Z Brooker; J P Friedman; A F Graham; H J Matlof; D C Harrison
Journal:  Circulation       Date:  1975-06       Impact factor: 29.690

Review 4.  Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.

Authors:  E M Antman; P H Stone; J E Muller; E Braunwald
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

5.  Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.

Authors:  M G Zyvoloski; H L Brooks; G J Gross; D C Warltier
Journal:  J Pharmacol Exp Ther       Date:  1982-08       Impact factor: 4.030

6.  Cardiovascular effects of verapamil in patients with essential hypertension.

Authors:  R E Schmieder; F H Messerli; G E Garavaglia; B D Nunez
Journal:  Circulation       Date:  1987-05       Impact factor: 29.690

7.  Increased exercise tolerance after oral diltiazem, a calcium antagonist, in angina pectoris.

Authors:  Y Koiwaya; M Nakamura; A Mitsutake; S Tanaka; A Takeshita
Journal:  Am Heart J       Date:  1981-02       Impact factor: 4.749

8.  Responses of coronary collateral flow and dependent myocardial mechanical function to the calcium antagonist, diltiazem.

Authors:  D Franklin; R W Millard; T Nagao
Journal:  Chest       Date:  1980-07       Impact factor: 9.410

9.  Nifedipine prevents sympathetic vasoconstriction distal to severe coronary stenoses.

Authors:  G Heusch; A Deussen
Journal:  J Cardiovasc Pharmacol       Date:  1984 May-Jun       Impact factor: 3.105

10.  Myocardial blood flow and function with critical coronary stenosis in exercising dogs.

Authors:  K P Gallagher; G Osakada; M Matsuzaki; W S Kemper; J Ross
Journal:  Am J Physiol       Date:  1982-11
View more
  4 in total

Review 1.  Pharmacology of acute effort angina.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

2.  Effect of amlodipine on myocardial functional and metabolic recovery following coronary occlusion and reperfusion in dogs.

Authors:  G J Gross; N E Farber; G M Pieper
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

3.  Beneficial actions of amlodipine in the multiple-stunned canine myocardium.

Authors:  G J Gross; G M Pieper
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

Review 4.  Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.